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In the 1960s, Rosenberg and his colleagues confirmed the anti-cancer activity of
cisplatin. Although cisplatin was capable of killing testicular cancer cells there were also
serious side effects. It was necessary to find alternate ways of overcoming side effects,
and soon many researchers have discovered novel platinum compounds that show similar
reactivity. Recently, replacing one chloride group to a heterocyclic amine group showed
significant cytotoxicity with a different binding activity than cisplatin. Previously in our
lab, [Pt(Me5dien)(NO3)]+ and [Pt(Et2dien)Cl]+ have been synthesized and reacted with NAcetyl-L-methionine (N-AcMet) and Guanosine 5’-monophosphate (5’-GMP) showed
unusual reactivity. Unlike most previously studied platinum triamine compounds,
Me5dien compound was reacting faster with 5’-GMP than N-AcMet, due to the bulkiness
of the triamine ligand. When both N-AcMet and 5’-GMP were reacted with Et2dien, 5’GMP displaced one amine group of the triamine ligand and replaced that spot to form a
bis-adducts, when the pH was kept below 4. Here a new novel platinum compound has
been synthesized with a seven-membered chelate ring triamine ligand, Chloro[2-(4methyl-1,4-diazepan-1-yl)ethanamine]platinum(II) chloride ([Pt(L)Cl]+). The unusual
binding activity of [Pt(L)Cl]+ showed a unique pair of products under 1H NMR, 195Pt
NMR and LC/MS spectrometry.

vii

I. Introduction
a. Introduction of cisplatin
In 1960s, Barnett Rosenberg and his colleagues, first discovered the anti-cancer
activity of platinum compound using various platinum complexes including the very first
platinum model, cisplatin (Figure 1), synthesized by Michele Peyrone in 1844.1,2 While
Rosenberg was doing an experiment on electrolysis of platinum mesh electrode in
Escherichia coli, found as platinum ions were leaching into the ammonia-containing
medium, there was no cell division in bacteria.1–3 Out of many different platinum
complexes, cisplatin was the most potent one. In 1978, cisplatin has been acknowledged
for its cytotoxic activity in testicular cancer cells and then approved by the U.S. FDA for
medical usage.4 Soon, many analogs of platinum compounds were tested, but only
carboplatin and oxaliplatin have achieved the approval as a chemotherapy drug in 1979
and 1994, respectively (Figure 1). So far, cisplatin is one of the most commonly used
chemotherapeutic drugs.

Figure 1. U.S. FDA approved platinum compounds
Adapted from reference 9
b. Mechanism of cisplatin
The apoptotic mechanism of cisplatin is divided into four main steps.2,3 The first step
is, the drug enters the cell. The second step is the hydrolysis reaction, in which chloride
groups are replaced by water molecules.5 The hydrolysis reaction is described below:
1

Pt(𝑁𝐻3 )2 𝐶𝑙2 + 𝐻2 𝑂 → [Pt(NH3 )2 𝐶𝑙(𝐻2 𝑂)]+ + 𝐶𝑙 −
[Pt(NH3 )2 𝐶𝑙(𝐻2 𝑂)]+ + 𝐻2 𝑂 → [Pt(NH3 )2 (𝐻2 𝑂)2 ]2+ + 𝐶𝑙 −
Equation 1. Hydration of cisplatin
The third step is the replacement of water molecules to DNA bases. Then, finally, the
DNA interaction of cisplatin causes a cytotoxic lesion, and this leads to the induction of
cellular death by apoptosis through many signal pathways.1,3
Typically, when platinum starts to interact with either DNA or protein, there are two
binding activities: monofunctional and bifunctional. Bifunctional activity is the most
abundant reactivity shown in traditional platinum compounds including cisplatin,
oxaliplatin, and carboplatin.5 A platinum compound with a bifunctional binding activity
has two leaving groups that interact with either two DNA bases or amino acids. For
example, when cisplatin reacts with two N7 of guanine bases, there can be formed two
guanine adducts: 1,2-d(GpG) or (GpA) intrastrand (Figure 2A) and G-G interstrand
crosslinks (Figure 2C). Intrastrand crosslink occurs within the same DNA strand with the
bases adjacent to another. Interstrand crosslink forms covalent bonds across DNA
strands. On the other hand, a platinum compound with the monofunctional activity only
replaces one leaving group, and react with either one guanine base (Figure 2B) or one
amino acid.5,6 The reaction with the protein is similar to the nucleobase, whether
depending on the type of activity, a platinum compound can bind to either one or two
amino acids.
Even though cisplatin and many platinum compounds have shown the anti-cancer
reactivities, the exact mechanism is still unclear.2 Cancer is itself is not a single defect at
a single site, but a complex which is can occur at any location of the body. Therefore,
many types of cancers show different features, and so, despite the finding of cytotoxic
2

platinum compounds is important, it is still required to have a better understanding of
cancer mechanisms to optimize the best efficacy of the drug.

Figure 1. Different binding types of platinum compound A. Intrastrand cross-link, B.
Monofunctional, and C. Interstrand cross-link
Adapted from reference 4.
c. Side effects of cisplatin
Although cisplatin and its analogs have the ability to kill cancer cells, they also kill
normal healthy cells due to cytotoxicity. Platinum is a heavy metal, and therefore it is
poisonous to the human body specifically.2,7 So, platinum compounds can cause toxic
effects by interacting multiple signaling pathways and protein while being transported to
different locations. Those platinum related side effects are severe kidney problems,
allergic reactions, decreased immunity to infection, gastrointestinal disorders,
hemorrhage, and hearing loss in some younger patients.
Another problem arises from the constant usage of platinum complexes. They can
accumulate within the cell, and this can actually result in one of the drug resistance
mechanisms.1,2,8 For example, recently, the copper membrane transporter 1 (Ctr1) was
known to be the main transporter for cisplatin’s cellular uptake.1 Constant usage of
cisplatin can actually degrade the Ctr1, and therefore the influx of cisplatin is limited, and
3

cause the drug resistance. However, the mechanism of platinum accumulation is still not
fully understood, so, further study is needed.
d. Phenanthriplatin
Due to the side-effects and the possible drug resistance, other novel platinum
compounds have been tested for their cytotoxic activity. Out of many compounds,
platinum with monofunctional binding activity has shown significant cytotoxicity with
various cancer cell lines.6,9,10 Especially, phenanthriplatin, a derivative of pyriplatin [cisdiamminepyridinechloro-platinum(II)], showed much higher cytotoxic effect than
cisplatin (Figure 3).

Figure 3. Pyriplatin and Phenanthriplatin
Adapted from reference 9
Based on the structure of phenanthriplatin, it replaced one chloride group of cisplatin
to a heterocyclic amine group and had an extra positive ion.3,11 This extra cation led the
compound to be hydrophobic and increased the cellular uptake greater than cisplatin.9
Also, the large amine ligand increased the binding to the DNA base and therefore
increased the cytotoxic effect more than other compounds. When the mono-adduct is
formed by the interaction of phenanthriplatin with DNA base, this action induced a slight
distortion at the DNA, and then this distortion inhibits transcription while eluding the
repair significantly.3,9
4

e. Previous research
Research has shown that platinum with an amine ligand could cause cytotoxicity,
[Pt(Me5dien)(NO3)]+ and [Pt(Et2dien)Cl]+ have been synthesized and tested for their
reactivity with N-AcMet and 5’-GMP in our lab (Figure 4).12,13

Figure 4. Previously synthesized Me5dien compound and Et2dien compound
Adapted from reference 12
Both compounds displayed unusual reactivities; from the Me5dien compound, for the
first time, 5’-GMP reacted kinetically faster than N-AcMet. Generally, the anti-cancer
platinum complex prefers to react with the thioether group faster than the nucleobase due
to the platinum’s high binding affinity of sulfur-containing molecules.9,12 When the
reaction rate of the Me5dien compound with N-AcMet and 5’-GMP were tested, 5’-GMP
reacted much faster than N-AcMet.13 This result could be due to the bulkiness of the
triamine ligand, which caused the steric clashes between the methyl groups of the ligand
and N-AcMet. A similar activity was observed for pyridine and phenanthriplatin as well,
the size of phenanthridine’s heterocyclic group is larger than pyridine, so the latter was
reacting faster with N-AcMet than the previous one.9
In the case of Et2dien compound, the triamine ligand was somewhat less bulky than
the Me5dien ligand, so the usual preference of N-AcMet over 5’-GMP was observed.
5

Interestingly, the Et2dien compound showed a unique product formation at a low pH.
Since this compound was a non-C2 symmetrical compound, multiple mono-adduct
signals could be observed by the 1H NMR spectroscopy. For example, when the
compound was reacted with 5’-GMP, rotational isomers were formed. And with NAcMet, interestingly, when the pH was kept below 4 for the entire reaction, one
intermediate resonance was observed, and this converted into a final form over time.
However, if the pH was kept higher than 4, the intermediate was never observed.
Furthermore, when both N-AcMet and 5’-GMP were added simultaneously, Et2dien’s
chelate ring structure opened, and both ligands formed a bond with platinum, which
produced a ring-opened product. This result could be due to the inter-ligand strain of the
structure, and to relieve this odd structure, one of the amine groups displaced from the
platinum, and led two incoming adducts to form a new bond. Also, the unusual activity
observed along different pH values could be due to the center nitrogen atom, which has
secondary nitrogen, and its hydrogen can be easily protonated or deprotonated.
f. My research
For my research, under the supervision of Dr. Kevin Williams, a novel platinum
compound has been designed and synthesized using a seven-membered chelate ring
ligand. We specifically chose this ligand because previously, a triamine ligand with the
center nitrogen being a secondary atom showed an interesting result like the
transformation of monofunctional to a bifunctional binding activity or the hindrance of
the bulkiness on the reaction rate. So, we were interested in how a tertiary center
nitrogen-containing ligand would react with the DNA nucleobase and the amino acid.
Then, we chose to use N-AcMet and 5’-GMP to react with. An amino acid with a
6

thioether plays an important role in protein uptake and efflux by being involved in the
copper transporter 1 (Ctr1). Guanine base was known to be the primary target of platinum
compounds to cause cytotoxicity. The reactions were checked under 1H and 195Pt NMR
spectroscopies and mass spectrometry.

7

II. Materials and Methods
a. Reagents
Potassium tetrachloroplatinate(II) (K2PtCl4) 2-(4-Methyl-1,4-diazepan-1-yl)ethanamine,
Guanosine 5’-monophosphate, N-Acetyl-L-methionine, 2-Hydroxy-4(methylthio)butyrate, and 9-Ethylguanine are all from Sigma Aldrich. Hydrochloric acid
(HCl) (concentrated and 1 M) and 99.9% Deuterium Oxide (D2O) are all from Sigma
Aldrich.
b. Synthesis of Chloro[2-(4-methyl-1,4-diazepan-1-yl)ethanamine] platinum(II)
([Pt(L)Cl]+, where L = 2-(4-Methyl-1,4-diazepan-1-yl)ethanamine)
In a 50 mL round-bottom beaker, 500 mg of Potassium tetrachloroplatinate(II) (K2PtCl4),
500 mg of 2-(4-Methyl-1,4,-diazepan-1-yl)ethanamine (L) and 20 ml of DI water were
dissolved. Then, concentrated HCl was added dropwise to approximately pH 4~5. Next, 1
M HCl was added to adjust pH to around 3~3.5. The solution was stirred and heatrefluxed for about 6 hours until the color changed from a reddish/orangish color to a
yellowish color. Once the yellowish color started to appear, the heat/reflux was turned off
and left it only stirring for overnight. The remaining solution was syringe-filtered. The
filtered solution was decreased until precipitates were formed by using the rotovap at
40~50 °C. The solution with precipitates was gravity-filtered and dried overnight. Any
precipitate in the beaker was washed with ethanol and collected. The filtered compound
was scraped off from the filtering paper. Finally, the compound was delivered to a 1.5
mL Eppendorf safe lock tube for storage. Typically, the yield was calculated to be ~40%
after the synthesis.
8

c. Preparation of [Pt(L)Cl]+ in D2O
For each experiment, 4.2 mg of [Pt(L)Cl]+ has been prepared with 1 mL of 99.9% D2O in
a 5 mm NMR tube.
d. Preparation of interaction of [Pt(L)Cl]+ with Sodium Chloride (NaCl)
4.2 mg of [Pt(L)Cl]+, 5 mg of NaCl, and 1 mL of D2O have been added to a 5 mm NMR
tube, and mixed. An additional amount of NaCl was used as there was no change in the
spectrum observed.
e. Preparation of interaction of [Pt(L)Cl]+ with N-Acetyl-L-methionine (NAcMet)
4.2 mg of [Pt(L)Cl]+, 1.9 mg of N-AcMet, and 1 mL of D2O have been prepared in a 5
mm NMR tube. As necessary, an additional amount of N-AcMet was used.
f.

Preparation of interaction of [Pt(L)Cl]+ with 2-Hydroxy4(methylthio)butyrate (But)

4.2 mg of [Pt(L)Cl]+, 1.6 mg of But, 1 mL of D2O have been prepared in a 5 mm NMR
tube. An additional amount of But was used in a need.
g. Preparation of interaction of [Pt(L)Cl]+ with Guanosine 5’-monophosphate
(5’-GMP)
4.2 mg of [Pt(L)Cl]+, 4.1 mg of 5’-GMP, and 1 mL of D2O have been prepared in a 5 mm
NMR tube.
h. Preparation of interaction of [Pt(L)Cl]+ with 9-Ethylguanine (9-EtG)
9

8.2 mg of 9-EtG was first dissolved in 0.2 mL of dimethyl sulfoxide (DMSO) and then
added to 4.2 mg of [Pt(L)Cl]+ and 1 mL of D2O in a 5 mm NMR tube. The amount of 9EtG was varied as needed.
i. Preparation of competition of [Pt(L)Cl]+ with N-AcMet and 5’-GMP
4.2 mg of [Pt(L)Cl]+, 4.1 mg of 5’-GMP, 1.9 mg of N-AcMet, and 1 mL of D2O have
been prepared in a 5 mm NMR tube. The amount of 5’-GMP and N-AcMet varied as a
necessity.
j. pH Adjustment
In order to increase the pH, both 1% and 10% of Sodium deuteroxide have been used. To
lower the pH, both 1% and 10% Deuterated nitric acid have been used.
k. Nuclear Magnetic Resonance (NMR) Spectroscopy
A JEOL 500 MHz NMR spectrometer has been used to collect the 1H and 195Pt NMR
data. For each 1H NMR spectrum, a single-pulse experiment was set up for a total of 8
scans for 1 min. For the 195Pt NMR, the number of scans has been set up differently for
each experiment as needed. Spectra have been referenced to residual HOD signal (1H) or
K2PtCl6 (195Pt).
l. Mass Spectrometry
A Varian Liquid Chromatography/ Mass Spectrometry 500 Ion Trap instrument from the
WKU Center for Research & Development was used for the mass spectrum. Each mass
spectrum has been set up with 10 µL sample, 500 µL LC/MS graded water, and 500 µL
LC/MS graded methanol. LC/MS grade methanol was used for the HPLC mobile phase
10

and 50:50 of methanol and 0.1% formic acid was in the solvent. All the spectra were
collected under the positive mode using an m/z range from 300 to 1200. The samples
were injected through the direct infusion.
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III. Results
a. Characterization of [Pt(L)Cl]+

Chloro[2-(4-Methyl-1,4-diazepan-1-yl)ethanamine]platinum(II) chloride
[Pt(L)Cl]+
Figure 5. Chemical structure of [Pt(L)Cl]+
Chloro[2-(4-Methyl-1,4-diazepan-1-yl)ethanamine]platinum(II) chloride
(=[Pt(L)Cl]+) showed a pale-yellow color when the synthesis was successful. The
chemical structure of [Pt(L)Cl]+ shows there are three amine groups with a sevenmembered heterocyclic ring and one chloride group attached to the center platinum
(Figure 5). Pt, three nitrogens, and the chloride are within the same plane geometry. Since
the triamine ligand was non-C2 symmetrical with two chiral nitrogens within the sevenmembered ring structure, the compound could generate enantiomers and racemic
mixtures. The chirality of both nitrogens was assigned the same.
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Figure 6. 195Pt NMR spectrum of [Pt(L)Cl]+
A fresh sample was set up for a 195Pt NMR with 80,000 scans for a better
understanding of ligands’ coordination to the platinum. A significant peak was observed
at approximately -2290 ppm, and this was corresponding to the PtN3Cl (Figure 6). The
result indicated that [Pt(L)Cl]+ has all three nitrogens of the ligand coordinated.
Then, approximately 4.2 mg of [Pt(L)Cl]+ has been dissolved in 1.0 mL D2O for
the solubility check under the 1H NMR. Since the triamine ligand was slightly acidic, the
pH was around ~3.5 without adjusting. The spectrum showed a singlet at 2.9 ppm, and
one resonance at 2.7 ppm. Over time, 2.7 ppm peak increased in size (Figure 7), and this
clued there was a hydrolysis reaction. Thus, the 2.9 ppm was assigned to the CH3 of the
ligand of [Pt(L)Cl]+ and the 2.7 ppm signal was for [Pt(L)(OH)]+.
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Figure 7. [Pt(L)Cl]+ in D2O pH unadjusted
A fresh sample was analyzed as before except NaCl was added to see whether
there is any change with those two signals. After 1 hour of adding NaCl, there was just a
slight change with the 2.7 ppm peak. Then, an excess amount of NaCl has been added
and checked again after 24 hours (Figure 8). The [Pt(L)(OH)]+ peak was bigger than the
chloride related peak, and there was no evidence of the latter peak’s growth in size.

14

Figure 8. [Pt(L)Cl]+ with excess NaCl at pH 7
Another reaction has been set up with an excess amount of HCl to keep the pH of the
sample below 3. The proton NMR spectrum showed no conversion of 2.9 ppm peak into
2.7 ppm peak (Figure 9). However, when the same sample’s pH was increased to 10, the
hydrolysis reaction occurred immediately. Also, no [Pt(L)Cl]+ peak was observed, but
[Pt(L)OH]+ peak was dominant. When pH was decreased to 4, no chloride related
resonance was observed and proved the hydrolysis reaction is irreversible.

15

Figure 9. [Pt(L)Cl]+ with HCl (pH adjusted)
b.

1H

NMR spectrum of [Pt(L)Cl]+ with N-AcMet in different conditions: ligand

ratio and pH
A new sample has been prepared with an equivalent amount of N-AcMet with no
pH adjustment. Both [Pt(L)Cl]+ and N-AcMet are acidic, the pH is expected to be around
~3 and 4. The 1H NMR spectrum showed two singlet peaks at 2.0 pm and 2.1 ppm at 20
min corresponding to unreacted N-AcMet. Also, add to that, a set of [Pt(L)(N-AcMet)]+
peaks at 2.05 ppm and 2.4 ppm. After a day, the 2.4 ppm peak kept growing in size, and a
new peak started to grow at 2.6 ppm. Over time, the initial 2.4 ppm peak converted into
the 2.6 ppm peak (Figure 10). There was no evidence where the 2.6 ppm peak converted
back to the 2.4 ppm peak. The same sample was prepared at pH 7. However, unlike at pH
16

4, there was no conversion occurred from the 2.4 ppm peak into the 2.6 ppm peak (Figure
11). Since pKa of Pt-coordinated water molecules are between ~5.5 and 6.5, this possibly
slowed the displacement of -OH from the center platinum and led to no formation of 2.6
ppm peak.

Figure 10. [Pt(L)Cl]+ with N-Acetyl-L-Methionine 1:1 ratio pH unadjusted
To find out what is causing the initial peak to convert into the other, two different
experiments were completed. The first sample was with only half the amount of NAcMet (Figure 12) and the second sample was prepared with a double amount of NAcMet (Figure 13). Since previous experiments reacted faster at pH 4, both samples were
reacted at pH 4. Those two samples showed similar results within 20 min of dissolving in
D2O. However, half the amount of N-AcMet has only shown 2.4 ppm peak even after 8
17

days. On the other hand, a double amount of N-AcMet showed a direct formation of a 2.6
ppm peak within 1 day. When this sample was checked again after 7 days, 2.6 ppm peak
has grown, but again no other peaks were observed.

Figure 11. [Pt(L)Cl]+ with N-Acetyl-L-Methionine 1:1 ratio pH 7
The conversion of 2.4 ppm to 2.6 ppm is inevitable, and the amount of unreacted NAcMet plays an important role here. Since [Pt(L)Cl]+ has a non-C2-symmetrical ligand,
when there is mono-adduct formation, the bond between Pt and adduct could rotate, and
therefore, different conformations are possible.
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Figure 12. [Pt(L)Cl]+ with N-Acetyl-L-Methionine 1:0.5 ratio at pH 4

19

Figure 13. [Pt(L)Cl]+ with N-Acetyl-L-Methionine 1:2 ratio at pH 4
c.

195Pt

NMR spectrum of [Pt(L)Cl]+ with N-AcMet

To confirm the hypothesis of the N-AcMet reaction is a monofunctional activity,
a 195Pt NMR spectrometer was done with a fresh sample with a 1:1 ratio of [Pt(L)Cl]+ and
N-AcMet at pH 4. This sample has been sitting for a long time, and so we have assumed
that the reaction was done and would have a dominant 2.6 ppm peak. A total of 96,000
scans have been collected over 12 hours. A significant peak was found at -3300 ppm,
which is related to the species with the 2.6 ppm peak in the 1H NMR spectrum, with a
PtN3S (Figure 14). This result established the reaction with N-AcMet forms a monoadduct (Figure 15). Since based on the 1H-NMR there are two mono-product peaks at 2.4
and 2.6 ppm (Figure 10). We wanted to make sure that the 2.4 ppm dominant sample
20

would show a similar result as the 2.6 ppm dominant sample. We have made a fresh
sample with less amount of N-AcMet to keep the sample would only have 2.4 ppm peak.
The same 195Pt NMR set-up as previous has been used, and the resulting spectrum
showed a different significant peak at -3190 ppm than the previous one. This chemical
shift was corresponding to the PtN2SCl range (Figure 16). This meant, the initial 2.4 peak
is a chelate ring-opened structure (Figure 17).

Figure 14. 195Pt NMR of [Pt(L)Cl]+ with N-AcMet 2.6 ppm peak

21

Figure 15. PtN3S structure

Figure 16. 195Pt NMR of [Pt(L)Cl]+ with N-AcMet 2.4 ppm peak

22

Figure 17. PtN2SCl structure
d. Mass spectrum of [Pt(L)Cl]+ with N-AcMet
In order to prove the reaction with N-AcMet is a monofunctional binding activity,
a mass spectrum was collected using the liquid chromatography/ mass spectrometry
instrument. Before we operated the mass spec, we have calculated the mass-to-charge
ratios of all the possible structures of platinum with N-AcMet and 5’-GMP (Table 1).
Possible Structures
m/z ratio
[Pt(L)Cl]+ w/ HCl lost
351
+
[Pt(L)OH]
368
[Pt(L)Cl]+
387
+
[Pt(L)(9-EtG)]
530
+
[Pt(L)(N-AcMet)]
542
[Pt(L)(9-EtG)]+ (ring-opened)
566
+
[Pt(L)(N-AcMet)] (ring-opened)
578
[Pt(L)(9-EtG)2]
709
+
[Pt(L)(5’-GMP)]
714
[Pt(L)(N-AcMet)2]
733
+
[Pt(L)(5’-GMP)] (ring-opened)
750
[Pt(L)(N-AcMet)(5’-GMP)]
905
[Pt(L)(5’-GMP)2]
1077
Table 1. Possible structures of [Pt(L)Cl]+ with N-AcMet, 9-EtG, and 5’-GMP
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LC/MS of N-AcMet at pH 4

Pt HCl lost
351

[Pt(L)Cl]+
387
[Pt(L)(N-AcMet)]+
ring-closed
542
[Pt(L)(N-AcMet)]+
ring-opened
578

Figure 18. Mass spectrum of [Pt(L)Cl]+ with N-AcMet at pH 4
First LC/MS was done with an N-AcMet reaction-finished sample. This sample contained
both 2.4 and 2.6 ppm peaks in the 1H NMR spectrum. The result showed four significant
peaks, and two of them were [Pt(L)Cl]+ product peaks (Figure 18). One was
corresponding to a product where the triamine ring structure is closed, and the other one
was ring-opened structure according to Table 1.

LC/MS of N-AcMet 2.6 ppm dominant
[Pt(L)Cl]+
387
Pt HCl lost
351
[Pt(L)(N-AcMet)]+
ring-closed
542

Figure 19. Mass spectrum of [Pt(L)Cl]+ with concentrated N-AcMet
Another LC/MS was done and for this time, the sample only had the 2.6 ppm peak
(Figure 19). Unlike the previous data, the spectrum only showed platinum coordinated to
one N-AcMet, where the ring structure was still closed.
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e.

1H

NMR spectrum of [Pt(L)Cl]+ with 2-Hydroxy-4(methylthio)butyrate with

the addition of But over time
A new sample has been set up with one equivalent ratio of 2-Hydroxy4(methylthio)butyrate (But). The structure of But is similar to N-AcMet and therefore we
expected to see similar product formation patterns unless the N atom of N-AcMet is
coordinating to the Pt. Unreacted But turned into products within one day. As seen,
similar 2.4 ppm and 2.6 ppm peaks were observed from 1H NMR as for the N-AcMet. An
additional amount of But has been added to the same sample and conversion of 2.4 peak
into 2.6 peak was observed over time (Figure 20).
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Figure 20. [Pt(L)Cl]+ with 2-(Hydroxy)-4(methylthio)butyrate
f.

1H

NMR spectrum of [Pt(L)Cl]+ with Guanosine 5’-monophosphate in

different conditions: ligand ratio, pH, and temperature
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Figure 21. [Pt(L)Cl]+ with Guanosine 5’-monophosphate at pH 4
When 5’-GMP was reacted with [Pt(L)Cl]+ at pH 4, multiple product signals have
been observed between 8.0 ppm and 9.0 ppm (Figure 21). Over time, those peaks grew in
size until there was no unreacted 5’-GMP remaining. At pH 7, product peaks only
appeared between 8.6 ppm and 9.0 ppm (Figure 22). As mentioned before, [Pt(L)Cl]+ is
non-C2-symmetrical and has chiral nitrogens. 5’-GMP can form two sets of rotational
isomers and two sets of enantiomers to be resolved. Therefore, four mono singlets are
observed. This sample’s temperature has been gradually raised and checked with 1H
NMR. Four peaks started to coalesce into one broad peak as temperature increased
(Figure 23). At 60°C, all peaks merged into one, but once the temperature hit 80 °C, the
peaks started to separate again. This clearly explained the products between 8.6 ppm and
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9.0 ppm are from two different mono-products which are because [Pt(L)Cl]+ has a
racemic mixture.

Figure 22. [Pt(L)Cl]+ with Guanosine 5’-monophosphate at pH 7
When half the amount of 5’-GMP was reacted with [Pt(L)Cl]+ at pH 4, a similar pattern
was observed as one equivalent amount was reacted. Again, multiple products peak
formed, and peaks from 8.0 ppm to 8.6 ppm could possibly be bis-products (Figure 24).
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Figure 23. [Pt(L)Cl]+ with Guanosine 5’-monophosphate at pH 7 with different
temperatures
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Figure 24. [Pt(L)Cl]+ with half amt. of Guanosine 5’-monophosphate at pH 4
g. Mass spectrum of [Pt(L)Cl]+ with 5’-GMP
Since the reaction with 5’-GMP showed multiple peaks at pH 4 under the 1H NMR
spectrum, a sample in which the reaction was started at pH 4 has been used for the
LC/MS to verify the characteristics of the peaks. According to the mass spectrum, there
were two significant peaks from 5’-GMP related products. One peak matched with
platinum coordinated to one 5’-GMP, and the other one corresponded to two 5’-GMPs
bonded to platinum (Figure 25).
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LC/MS of 5’-GMP at pH 4
Pt HCl lost
351

[Pt(L)(5’-GMP)]+
714

[Pt(L)(5’-GMP)2]
1077

Figure 25. Mass spectrum of [Pt(L)Cl]+ with 5’-GMP at pH 4
h.

1H

NMR spectrum of [Pt(L)Cl]+ with 9-EtG in different conditions: ligand

ratio, pH, and temperature
9-Ethylguanine was used to understand the reaction of [Pt(L)Cl]+ with 5’-GMP
better. At the beginning of the experiment, 9-EtG was not soluble in water We used 200
μL of dimethyl sulfoxide (DMSO) to dissolve it first, then added to D2O with no pH
adjustment. 9-EtG was acidic, the sample’s pH was expected to be around ~4 and 5.
Within 20 min of the reaction, only unreacted 9-EtG was observed under the 1H NMR
(Figure 26). After 24 hours, [Pt(L)(9-EtG)]+ resonance was detected and over time,
multiple peaks developed. Interestingly, two singlets at 8.2 and 8.8 ppm, started to
decrease, and the broad peak at 8.45 ppm increased (Figure 26). When a fresh sample
was made at pH 7, the reaction rate was much faster than there was no pH adjustment.
Within 6 days of the reaction, two singlets at 8.2 and 8.8 ppm disappeared, only a broad
resonance was observed at 8.4 ppm (Figure 27). In addition to that, the pH shift of
unreacted 9-EtG was large, the sample’s pH had to be adjusted to 7 every day.
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Figure 26. [Pt(L)Cl]+ with 9-Ethylguanine with no pH adjustment
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Figure 27. [Pt(L)Cl]+ with 9-Ethylguanine at pH 7
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Figure 28. [Pt(L)Cl]+ with half amt. of 9-Ethylguanine with no pH adjustment
To better understand whether the reaction rate was affected by the concentration of
unreacted 9-EtG or the pH, another sample was prepared with 0.5 equimolar of 9-EtG at
pH 4. Again, the conversion of two initial singlets to the broad resonance was observed
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over time (Figure 28). However, even after 21 days of the reaction, peaks at 8.2 and 8.8
ppm remained in a good size. The reaction rate could be affected by the pH possibly.
i.

1H

NMR spectrum of [Pt(L)Cl]+ with 5’-GMP and N-AcMet in different

conditions: ligand ratio, pH, and temperature
Both N-AcMet and 5’-GMP have been added to [Pt(L)Cl]+ at pH 4
simultaneously (Figure 29). Within 20 min, Pt-N-AcMet coordinated resonance was
observed at 2.05 ppm and 2.4 ppm, however, 5’-GMP did not have any reaction. After 3
days, multiple 5’-GMP resonances were shown between 8.0 ppm and 9.0 ppm.
Interestingly, 2.05 ppm N-AcMet signal has decreased as [Pt(L)(5’-GMP)]+ formation.
This pattern tended to continue over time and evidenced that N-AcMet is being replaced
by 5’-GMP. Also, since not all N-AcMet products were replaced, another possibility is
both ligands were attached to platinum.
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Figure 29. [Pt(L)Cl]+ with 5’-GMP and N-AcMet at pH 4
Another competition was observed set up at pH 7 (Figure 30) under the 1H NMR. Unlike
the fast formation of 5’-GMP product, noticeable resonance showed only after 18 days.
As mentioned before, at pH 7, water molecules were deprotonated and therefore the
reaction rate was very slow. Although coordination of [Pt(L)Cl]+ with 5’-GMP was slow,
similar replacement activity was observed. Based on the results, when there is
competition, N-AcMet reacts faster than 5’-GMP, but the latter one slowly replaced the
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initial product, and add to that, both DNA nucleobase and amino acid can attach to
platinum.

Figure 30. [Pt(L)Cl]+ with 5’-GMP and N-AcMet at pH 7
A competition reaction was done with a 1:1:1 ratio of [Pt(L)Cl]+, N-AcMet, and 5’-GMP
and similar product formation was observed (Figure 31).
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Figure 31. [Pt(L)Cl]+ with both double amount of 5’-GMP and N-AcMet at pH 4
j. Mass spectrum of competition of 5’-GMP and N-AcMet with [Pt(L)Cl]+
An LC/MS spectrum was obtained from a reaction-finished competition sample at
pH 4. According to the result, there were three peaks from newly coordinated products:
one with single N-AcMet, one with single 5’-GMP, and one with both N-AcMet and 5’GMP bonded to the platinum (Figure 32).
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LC/MS of competition at pH 4
[Pt(L)Cl]+
387
Pt HCl lost
351

[Pt(L)(N-AcMet)]+
387
[Pt(L)(5’-GMP)]+
714
[Pt(L)(N-AcMet)(5’-GMP)]
1077

Figure 32. Mass spectrum of competition reaction at pH 4
The mass spec has shown [Pt(L)Cl]+ could actually have both monofunctional and
bifunctional reactivity under certain circumstances.
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IV. Discussion
Since Rosenburg’s finding on the anti-cancer platinum compound, much research
has been conducted. Recently, replacing one of the chloride group to a heterocyclic
amine group has shown significant cytotoxicity. Phenanthriplatin was recognized to be
the platinum compound with higher cytotoxicity, and also the hydrophobic amine ligand
would transport to the target site better than cisplatin. Typically, cisplatin would bind to
two DNA bases through either 1,2-d(GpG)/(GpA) intrastrand or GpG interstrand, and
make a lesion which induces multiple signaling pathways to generate cellular death, and
on the other hand, phenanthriplatin would distort the DNA helix with the large amine
ligands, and inhibit the transcription.5,9,14
Though the exact mechanism of how a platinum compound is being uptaken into
the cell and the source of the drug resistance is unclear, it is important to continue to test
various platinum derivatives. It has been proven the reaction with sulfur-containing
amino acids, like in metallothionein, plays an important role in the cellular uptake, and
efflux of the drug by being a key part of the copper transporter 1.9,12 However, the ability
of cisplatin to degrade Ctr1, it can also play a role in the drug resistance.
Generally, platinum compounds favor binding to sulfur-containing protein than
nucleobases due to its high binding affinity. On some occasions, this reactivity could be
reversed when there is a strong inter-ligand strain or the bulkiness of amine ligand.9,13
Here, a newly synthesized novel platinum compound, [Pt(L)Cl]+ has a paleyellow color. Almost immediately dissolving [Pt(L)Cl]+ into water started the hydrolysis
reaction (Figure 7), and a 1H NMR spectrum was gathered to check its solubility. The
replacement of the chloride to the hydroxide was expectable but this was highly
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dependent on pH values. When the pH was kept low with HCl, no hydrolysis reaction
was observed, but the same sample’s pH got increased to 10, there was an instant
replacement, which was irreversible. After the hydroxide resonance was observed from
the 1H NMR spectrum, we have added an excessive amount of NaCl, but there was no
change. To have a better understanding of the platinum to the ligand coordination, a 195Pt
NMR was generated. From the 195Pt NMR spectrum, a significant peak was found at
around -2300 ppm. According to Oehlsen et al., this range was corresponding to PtN3Cl,
which means three nitrogens of the triamine ligand are attached to the center platinum.15
Platinum compounds’ reaction with the protein is important and closely related to
the cellular uptake and efflux. In this experiment, N-AcMet was used because it is a key
structure of Ctr1. The reaction produced two different mono resonances within one day
(Figure 10). Interestingly, the initial peak merged into the latter one that appeared over
time. So, our first guess assumed that the initial peak is a less stable mono-product, which
turns into a final stable mono-product, as observed with the Et2dien compound, as time
passed. In the case of Et2dien compound, it would form an initial less-stable product
when the pH was below 4, and replaced by the final stable product. However, if the pH
was kept above 4, there was no initial product’s peak occurring, but the final product was
directly formed.12
Like the Et2dien compound, [Pt(L)Cl]+ is a non-C2 symmetrical compound, with
two chiral carbons, and the N-AcMet structure has one chiral sulfur. Once they start to
react, there are two improper torsion angles of the hydrogen on the triamine ligand.
Depending on the position of the methyl group attached to the sulfur, syn- and anti-
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conformations are possible. Therefore, a total of 8 different R, S combinations with being
syn or anti enantiomers were possible (Table 2).12
Chirality at both N
Chirality at S
Torsion
R
R
Syn
R
R
Anti
R
S
Syn
R
S
Anti
S
R
Syn
S
R
Anti
S
S
Syn
S
S
Anti
Table 2. Possible enantiomers of [Pt(L)Cl]+ with N-AcMet
Initially, we believed that the chloride or the hydroxide is replaced by one of 8
possible enantiomers to form a mono-product (Figure 15). Then slowly, unreacted NAcMet reacts with [Pt(L)Cl]+ and knocks off the initial mono-product and forming the
final stabilized mono-product.
Unlike the pH condition of the Et2dien compound, the reaction rate of [Pt(L)Cl]+
with N-AcMet could be manipulated by the amount of unreacted N-AcMet presence in
the sample. In low [unreacted N-AcMet], the conversion of the initial peak to the final
peak was extremely slow even after 8 days (Figure 12). However, with excess N-AcMet
presence, the final product was dominant within one day (Figure 13). To support the idea
of reaction rate relationship to the concentration, we used 2-hydroxy-4(methylthio)butyrate, which was the analog of a methionine (Figure 20).12 We started the
reaction with 1:1 ratio of [Pt(L)Cl]+ and within one day, we observed the formation of
both less stable and final stable products. Over time, we added an excess amount of But,
and a less stable peak decreased in size, and the final product’s peak increased.
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Our initial idea was incorrect after obtaining the result of the LC/MS. The mass
spectrometer showed two peaks which were coordinating to the mono-N-AcMet product,
and one was ring-opened and the other one was the ring-closed structure of N-AcMet
(Figure 18). The ring-opened structure could be possible due to the bulkiness of the
amine ligand. Since there were two mono-peaks from the 1H NMR, we wanted to identify
which peak was corresponding to which one of two structures. We generated two sets of
195

Pt NMR with one having the less-stable 2.4 ppm peak dominant, and the other one

having the final 2.6 ppm peak dominant. As we thought, the sample with the less-stable
product showed a significant peak at around -2190 ppm, and this was corresponding to
PtN2SCl. The sample with the final product showed a peak at around -2300 ppm, and this
was from PtN3S. Based on the mass spec and the 195Pt NMR, once N-AcMet starts to
interact with [Pt(L)Cl]+, one nitrogen would displace, and replaced by N-AcMet. Next,
unreacted N-AcMet would interact with [Pt(L)Cl]+ and form the final stable product,
where the triamine group is coordinated to the platinum with either the chloride or the
hydroxide displaced by N-AcMet (Figure 33).

+ N-AcMet
time

[Pt(L)Cl]+
+ N-AcMet (double amount)

initial 2.4 ppm product
final 2.6 ppm product

final 2.6 ppm product

Figure 33. Reaction scheme of [Pt(L)Cl]+with N-AcMet
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Based on the LC/MS spectrum, 1H NMR and 195Pt NMR, we conclude the
reaction with N-AcMet is producing a monofunctional binding activity and also,
depending on the amount of unreacted N-AcMet presence in the sample, the reaction rate
could change.
As mentioned before, there are two binding activities of the platinum compound
with DNA: monofunctional and bifunctional. Cisplatin typically showed a bifunctional
activity.1,2,9 Once cisplatin starts to react with nucleobases, it can form two types of
different covalent cross-links. The first type is GpG or GpA intrastrand cross-link. This
happens within the same DNA strand. The second type is GpG interstrand cross-link,
which happens between two adjacent DNA strands.5 On the other hand, phenanthriplatin
and pyriplatin bind to DNA monofunctional, and here they only react with the guanine
basex.9
The reaction of [Pt(L)Cl]+ with 5’-GMP showed a unique product formation
pattern. At pH 4, within one day, multiple product resonances were observed under the
1

H NMR. Over time, all the peaks increased in size until there was no unreacted 5’-GMP

remaining. At pH 7, and [Pt(L)(5’-GMP)]+ resonances were found between 8.6 ppm and
8.8 ppm. We hypothesized fewer product signals would occur due to the slow reaction
rate at pH 7. The pKa of a platinum compound with -OH group is between 5.5 and 6.5, so
the solution is deprotonated and due to the hydrolysis reaction, so there are more
[Pt(L)OH]+ than [[Pt(L)Cl]+.12 Since, two similar-sized peaks were observed at pH 4
these could linked to two sets of rotational isomers and their mirror images. To confirm
this idea, we have increased the pH 7 sample’s temperature and gathered the 1H NMR
spectra (Figure 23). At the room temperature, the interconversion of four peaks was slow,
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the peaks were clearly distributed. However, at 40°C, the peaks started to coalesce, and at
60°C, all the peaks sharpened into one. A similar result was seen in the Et2dien
compound, which also has a non-C2 symmetrical ligand. To identify those multiple
product peaks of [Pt(L)(5’-GMP)]+ at pH 4, we examined the LC/MS spectrometry.
Interestingly, two significant peaks were observed; one corresponding to a mono-adduct
of 5’-GMP, and the other one to bis-adduct of 5’-GMP, which in this case could happen
by displacing one of the amine groups. The ring-opening pattern was observed in Marzilli
group’s compound ([Pt(di-(6-methyl-2-picolyl)amine)Cl]Cl) as well.16

Figure 34. Unusual chelate ring-opening of a platinum compound
Adapted from reference 16.
The ring-opening was possible due to the methyl group of the triamine ligand causing a
steric hindrance, which led one of the amine group to displace (Figure 34).16 Since,
[Pt(L)Cl]+ has a bulky ligand at the side with the seven-membered ring, when there is a
second 5’-GMP, one of the amine groups could dissociate, and would be replaced by 5’GMP. However, no formation of bis-adduct was observed at pH 7, and this is still
unclear. In order to support the reaction with 5’-GMP, we did another experiment with 9Ethylguanine, which did not have the phosphate group or the chiral center, so it could
only product rotational isomers. Unlike 5’-GMP, preparing a sample with 9-EtG required
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additional steps. Dimethyl sulfoxide (DMSO) was used to dissolve unreacted 9-EtG
firstly, and then it was added to [Pt(L)Cl]+ and D2O. For this sample particularly, the pH
shift was big with the unreacted 9-EtG peak in the 1H NMR, the sample’s pH had to be
adjusted every time before running the NMR spectrometer. Within one day of the
reaction, two distinct singlets at 8.15 ppm and 8.8 ppm were observed under the spectra
(Figures 26, 27, and 28). Over time, these peaks converted into a broad peak at 8.4 ppm.
Referencing Marzilli group’s 1H NMR result, this conversion is the transformation of
mono-product to bis-product.16 Both 9-EtG and 5’-GMP reactions’ rate was highly
dependent on the pH, but unlike 5’-GMP, the conversion of mono- into bis-product was
inevitable whether there are more or less [unreacted 9-EtG].

+ 5'-GMP @ pH4

and
[Pt(L)Cl]+
+ 5'-GMP @ pH7

5'-GMP mono-product

5'-GMP bis-product

5'-GMP mono-product

Figure 35. Reaction scheme of [Pt(L)Cl]+ with 5’-GMP
Although the conversion of mono 5’-GMP into bis 5’-GMP is still unclear when the
reaction starts at pH 4, there are evenly distributed structures of platinum with chloride or
hydroxide, so both mono- and bis-products are possible. However, at pH 7, due to the
deprotonation of water molecules, the hydrophilic activity causes only mono-adducts
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formation (Figure 35). Unlike the reaction with N-AcMet, the concentration of 5’-GMP
did not affect the reaction rate (Figure 24).
Competition reaction of [Pt(L)Cl]+ with both N-AcMet and 5’-GMP is important
because due to the platinum compound’s soft ligand preference, N-AcMet forms faster
than 5’-GMP.9,12 However, reaction with N-AcMet could be slowed depending on the
bulkiness of the amine ligand. Previously, the Me5dien compound reacted faster with 5’GMP than N-AcMet, and phenanthriplatin favored reaction with 5’-GMP over N-AcMet
as well.9,13 When a competition was started at pH 4 with an equimolar amount of NAcMet and 5’-GMP, [Pt(L)Cl]+ favored to bind to N-AcMet faster than 5’-GMP (Figure
29). It took at least three days to react with 5’-GMP, and once the guanine related
resonances began to appear, methionine peaks started to decrease in size and evidenced
there is a replacement. Despite the conversion was observed, even after 9 days of
reaction, there were still N-AcMet coordinated products remaining. We hypothesized
there are both N-AcMet and 5’-GMP coordinated to platinum like the Et2dien compound.
Based on the 1H NMR of the competition reaction at pH 7, there was the immediate
formation of [Pt(L)(N-AcMet)]+ products, but unlike at pH 4, it took at least 18 days for
5’-GMP to form products. As seen in 5’-GMP reaction, since the competition was
generated at pH 7, only mono-products of 5’-GMP were formed. However, the
replacement of [Pt(L)(N-AcMet)]+ to [Pt(L)(5’-GMP)]+ happened as same as at pH 4.
According to the LC/MS spectrum of competition reaction at pH 4, there were multiple
peaks found. As we expected, [Pt(L)(N-AcMet)]+ and [Pt(L)(5’-GMP)]+ was detected,
and add to that [Pt(L)(N-AcMet)(5’-GMP)] peak was also detected. One possible
hypothesis is, once the competition begins, kinetically favored N-AcMet would dissociate
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one of the triamine group and take the spot. Over time, thermodynamically favored 5’GMP would displace either the chloride group or the hydroxide group to form a bisproduct. As the reaction with 5’-GMP is still unclear, we presume there are two possible
ways of product formation depending on the starting pH value (Figure 36&37).

+ N-AcMet&
5'-GMP
@ pH 4

Possibility

[Pt(L)Cl]+

initial 2.4 ppm product

Both N-AcMet & 5'-GMP attached to Pt

Figure 36. Reaction scheme of competition at pH 4
+ N-AcMet&
5'-GMP
@ pH 7

Possibilit

[Pt(L)Cl]+

initial 2.4 ppm product
Replacement of N-AcMet to 5'-GMP to Pt

Figure 37. Reaction scheme of competition at pH 7
A novel platinum compound, [Pt(L)Cl]+, was synthesized successfully and reacted
with N-AcMet and 5’-GMP. Like other typical platinum compounds, [Pt(L)Cl]+ preferred
to bind to the amino acid kinetically faster, but over time, the guanine base replaced NAcMet and formed stable product thermodynamically. Besides, the reactions with each of
N-AcMet and 5’-GMP showed unusual activity. There were two forms of [Pt(L)(NAcMet)+ products with one being ring-opened and the other one is ring-closed. Both
[Pt(L)(5’-GMP)]+ and [Pt(L)(5’-GMP)2] were observed when the reaction was generated
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at pH 4, but at pH 7, only mono-product was produced, and there was evidence of bisproduct formation.
[Pt(L)Cl]+’s future work would require two additional experiments. The first one
will be the study of molecular mechanics. Since rotational isomers and enantiomers were
possible, we still need to get the optimized structure with the minimum formation energy.
Also, this will help us to understand the dissociation of the chelate ring better, as well.
The second one is the biological study of [Pt(L)Cl]+ with different cancer cells. This
particular work will test the cytotoxicity and the cellular uptake of the compound.
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